Amgen's $897 Million Trading Volume Surges 52.81% to Rank 83rd Amid Investor Interest and Quarterly Profit Boost

On June 20, 2025, Amgen's trading volume reached $897 million, marking a 52.81% increase from the previous day, placing it 83rd in the day's stock market rankings. Amgen's stock price fell by 0.09%, marking the third consecutive day of decline, with a total decrease of 2.10% over the past three days.

Amgen has recently garnered significant attention from investors, as noted by users on Zacks.com. This heightened interest underscores the potential for the stock to experience notable movements in the near future.

Amgen reported increased quarterly profits, driven by strong sales performance. Additionally, the company is seeking to revive patents for its Repatha cholesterol-lowering drug, which could further bolster its financial outlook.